244 related articles for article (PubMed ID: 35741755)
21. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
22. Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single‑cell RNA sequencing data.
You Y; Yang Q
BMC Cancer; 2024 Feb; 24(1):207. PubMed ID: 38355446
[TBL] [Abstract][Full Text] [Related]
23. Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer.
Ding B; Yan W; Shen S; Meng D; Chen X; Wang S; Shen Y
Cancer Control; 2023; 30():10732748231168756. PubMed ID: 37078136
[TBL] [Abstract][Full Text] [Related]
24. An EMT-based gene signature enhances the clinical understanding and prognostic prediction of patients with ovarian cancers.
Li QJ; Wu ZL; Wang J; Jiang J; Lin B
J Ovarian Res; 2023 Mar; 16(1):51. PubMed ID: 36907877
[TBL] [Abstract][Full Text] [Related]
25. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
Ni X; Chen C; Cui G; Ding W; Liu J
Front Immunol; 2022; 13():932876. PubMed ID: 35837397
[TBL] [Abstract][Full Text] [Related]
26. Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma.
Zhang G
Discov Oncol; 2023 Nov; 14(1):203. PubMed ID: 37957420
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Guo F; Hong J
Front Genet; 2020; 11():441. PubMed ID: 32431729
[TBL] [Abstract][Full Text] [Related]
28. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
Zheng J; Zhang YW; Pan ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
[TBL] [Abstract][Full Text] [Related]
29. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer.
Pi Y; Sun F; Zhang Z; Liu X; Lou G
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
[No Abstract] [Full Text] [Related]
30. 5 signature genes revealed by single-cell profiling identified unique immune subtypes affecting the prognosis of ovarian cancer.
Xiang SY; Li QK; Yang Z; Yi Q
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2051-2062. PubMed ID: 38497886
[TBL] [Abstract][Full Text] [Related]
31. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
Xu H; Zou R; Liu J; Zhu L
J Oncol; 2021; 2021():6653247. PubMed ID: 33747079
[TBL] [Abstract][Full Text] [Related]
32. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
Chen M; Wang X; Wang W; Gui X; Li Z
Front Immunol; 2022; 13():829057. PubMed ID: 35833114
[TBL] [Abstract][Full Text] [Related]
33. Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer.
Liu Y; Liu S; Yan L; Zhang Q; Liu W; Huang X; Liu S
Mediators Inflamm; 2023; 2023():1400267. PubMed ID: 38022687
[TBL] [Abstract][Full Text] [Related]
34. A nine-gene signature related to tumor microenvironment predicts overall survival with ovarian cancer.
Ding Q; Dong S; Wang R; Zhang K; Wang H; Zhou X; Wang J; Wong K; Long Y; Zhu S; Wang W; Ren H; Zeng Y
Aging (Albany NY); 2020 Mar; 12(6):4879-4895. PubMed ID: 32208363
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a Hypoxia-related Prognostic Model for Ovarian Cancer.
Xie L; Pan M; Zhang Z; Jiang X; Chen Y; Liu G; Chen Y; Zeng Y; Guan J; Lu R; Zeng L
Recent Pat Anticancer Drug Discov; 2022; 18(2):161-173. PubMed ID: 35747984
[TBL] [Abstract][Full Text] [Related]
36. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma.
Huang XY; Qin WT; Su QS; Qiu CC; Liu RC; Xie SS; Hu Y; Zhu SY
Biomed Res Int; 2021; 2021():6669570. PubMed ID: 34671679
[TBL] [Abstract][Full Text] [Related]
37. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
Wang X; Li X; Wang X
J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
[TBL] [Abstract][Full Text] [Related]
38. Identification of hub genes and compounds controlling ovarian cancer stem cell characteristics via stemness indices analysis.
Wang Z; Wu D; Xia Y; Yang B; Xu T
Ann Transl Med; 2021 Mar; 9(5):379. PubMed ID: 33842600
[TBL] [Abstract][Full Text] [Related]
39. Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma.
Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J
Ann Transl Med; 2023 Jan; 11(2):61. PubMed ID: 36819514
[TBL] [Abstract][Full Text] [Related]
40. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
